We are live on
!
Find out more
HC
Hampstead Capital Portfolio holdings
AUM
$55.8M
1-Year Est. Return
2.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.14%
1 Year Est. Return
+2.76%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.3M
AUM Growth
–
Cap. Flow
+$91.3M
Cap. Flow
% of AUM
96.83%
Top 10 Holdings %
Top 10 Hldgs %
50.52%
Holding
29
New
29
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.17M |
| 2 |
AT&T
T
|
+$6.54M |
| 3 |
Viatris
VTRS
|
+$4.83M |
| 4 |
CELG
Celgene Corp
CELG
|
+$4.45M |
| 5 |
Apple
AAPL
|
+$4.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.07% |
| 2 | Communication Services | 17.14% |
| 3 | Technology | 12.68% |
| 4 | Energy | 12.25% |
| 5 | Financials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$143B
| $7.23M | 7.67% |
+234,726
| New | +$7.17M |
|
|
2
AT&T
T
$159B
| $7.12M | 7.55% |
+221,638
| New | +$6.54M |
|
|
3
Viatris
VTRS
$20.4B
| $4.96M | 5.26% |
+130,000
| New | +$4.83M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $4.63M | 4.91% |
+40,000
| New | +$4.45M |
|
|
5
Apple
AAPL
$4.54T
| $4.29M | 4.55% |
+148,000
| New | +$4.2M |
|
6
Royal Bank of Canada
RY
$291B
| $4.1M | 4.35% |
+45,100
| New | +$2.92M |
|
7
T-Mobile US
TMUS
$185B
| $4.03M | 4.27% |
+70,000
| New | +$3.66M |
|
8
Hewlett Packard
HPE
$63.4B
| $3.93M | 4.17% |
+292,495
| New | +$3.91M |
|
9
Microsoft
MSFT
$3.45T
| $3.73M | 3.96% |
+60,000
| New | +$3.61M |
|
10
Range Resources
RRC
$9.38B
| $3.61M | 3.83% |
+105,000
| New | +$3.76M |
|
|
PXD
11
DELISTED
Pioneer Natural Resource Co.
PXD
| $3.6M | 3.82% |
+20,000
| New | +$3.66M |
|
12
American International
AIG
$41.7B
| $3.59M | 3.81% |
+55,000
| New | +$3.45M |
|
13
General Motors
GM
$80.4B
| $3.31M | 3.51% |
+95,000
| New | +$3.19M |
|
14
The Mosaic Company
MOS
$7.03B
| $3.23M | 3.42% |
+110,000
| New | +$2.95M |
|
15
Southern Company
SO
$109B
| $3.08M | 3.27% |
+62,700
| New | +$3.08M |
|
16
Philip Morris
PM
$297B
| $3.08M | 3.27% |
+33,700
| New | +$3.12M |
|
17
Verizon
VZ
$195B
| $3.08M | 3.27% |
+57,700
| New | +$2.88M |
|
18
ExxonMobil
XOM
$644B
| $3.08M | 3.27% |
+34,100
| New | +$2.98M |
|
|
PPL
19
PPL Corp
PPL
$26.5B
| $3.05M | 3.24% |
+89,600
| New | +$3.01M |
|
20
Merck
MRK
$322B
| $3.04M | 3.22% |
+54,077
| New | +$3.16M |
|
21
Gilead Sciences
GILD
$162B
| $2.94M | 3.12% |
+41,000
| New | +$3.05M |
|
22
Teva Pharmaceuticals
TEVA
$40.8B
| $2.72M | 2.88% |
+75,000
| New | +$2.99M |
|
|
GG
23
DELISTED
Goldcorp Inc
GG
| $2.09M | 2.22% |
+154,000
| New | +$2.15M |
|
|
TWX
24
DELISTED
Time Warner Inc
TWX
| $1.93M | 2.05% |
+20,000
| New | +$1.78M |
|
25
RTX Corp
RTX
$290B
| $1.64M | 1.74% |
+23,835
| New | +$1.58M |
|
Similar funds
CCP
PAI
CLA
EIC
SF
DIV
MGPI
BOIA
Hampstead Capital's Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for Hampstead Capital, which disclosed 29 positions worth $94.3M. Its ten largest holdings account for 51% of the portfolio.
Its largest position is Pfizer: 234,726 shares worth $7.23M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, followed by Communication Services and Technology.
- Hampstead Capital's largest Q4 2016 buy was Pfizer: 234,726 shares worth $7.23M.
- Hampstead Capital's ten largest holdings make up 51% of its $94.3M portfolio in Q4 2016.
- Hampstead Capital disclosed 29 positions in Q4 2016, its first 13F filing on record.
Based on Hampstead Capital's 13F filing for Q4 2016, filed 14 Feb 2017.